Mallinckrodt Provides a Regulatory Update on Terlipressin
- Tuesday, February 22, 2022, 7:00
- Finance
- Add a comment
DUBLIN, Feb. 22, 2022 /PRNewswire/ — Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Company’s New Drug Application (NDA) seeking approval for…
About the Author
adminasapcorp has written 41555 stories on this site.